Alumis Inc. (ALMS) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -1011.7%, revenue growth -37.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $24.05M |
| Revenue (TTM) | $0.0B |
| Net Margin | -1011.7% |
| Return on Equity | -97.1% |
| Operating Margin (TTM) | -6204.4% |
| Current Ratio | 6.74 |
| Revenue Growth (YoY) | -37.7% |
| EPS Growth (YoY) | -242.3% |
| FCF Growth (YoY) | -23.6% |
| Price / Book | 2.59 |
| Price / Sales | 158.36 |
| FCF Yield | -30.0% |
| Altman Z-Score | -1.70 (distress) |
| Industry P/E (Pharmaceutical Products) | 15.1 |
| Sector P/E (Healthcare) | 19.4 |
ALMS overview · ALMS earnings · ALMS KPIs · ALMS documents · ALMS ownership · ALMS peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.